Cheryl Blanchard

Dr. Cheryl R.
Blanchard is an Executive in Residence at Clarevia Ventures, an Executive Chairman at Anika Therapeutics, Inc., a Member at National Academy of Engineering, a President & Manager at Parcus Medical LLC and a President, Chief Executive Officer & Director at ArthroSurface, Inc. She is on the Board of Directors at Xilio Therapeutics, Inc., Massachusetts Biotechnology Council, Elute, Inc., Lumicell, Inc., Surgicure Technologies, Inc. and ArthroSurface, Inc. Dr. Blanchard was previously employed as an Independent Director by Vigil Neuroscience, Inc., an Independent Director by Daré Bioscience, Inc., a President & Chief Executive Officer by Keratin Biosciences, Inc., an Independent Director by SeaSpine Holdings Corp., a President, Chief Executive Officer & Director by Microchips Biotech, Inc., a Principal by Blanchard Consulting LLC, a Chief Scientific Officer & SVP-Zimmer Biologics by Zimmer Biomet Holdings, Inc., a Chief Scientific Officer & Senior Vice President by Zimmer, Inc., a Manager by Southwest Research Institute, a Member-Supervisory Board by CeramTec GmbH, a President & Chief Executive Officer by Daré MBI, Inc., a Manager by Oak Ridge National Laboratory, a Manager by Texas University of Health Center at San Antonio, a Professor by University of Texas at San Antonio, and a Professor by University of Texas Health Center.
She also served on the board at Neuronetics, Inc., ISTO Technologies, Inc. and Novum Medical, Inc. She received her undergraduate degree from Alfred University, a graduate degree from The University of Texas at Austin and a doctorate degree from The University of Texas at Austin.